Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
19/03/2026 12:30
Removes reference to estimate for Q4 adjusted net income March 19 (Reuters) - Theravance Biopharma Q4 adjusted net income USD 3.131 million * Q4 net income USD 61.024 million * Q4 revenue USD 45.9 million vs. IBES estimate USD 58.5 million * Q4 EPS USD 1.15 ((Reuters.Briefs@thomsonreuters.com))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions